CJC-1295

CJC-1295 Product Description — Research Use Only

CJC-1295 is a synthetic research peptide analog of growth hormone-releasing hormone, commonly known as GHRH. It is commonly studied for its role in growth hormone signaling, IGF-1 pathway activity, pituitary response, metabolic research, and recovery-related biological pathways.

Research on CJC-1295 has most commonly focused on growth hormone release, IGF-1 signaling, protein synthesis pathways, fat-metabolism research, tissue-repair signaling, and body-composition-related markers. Published studies describe CJC-1295 as a long-acting GHRH analog that can increase growth hormone and IGF-1 activity while preserving pulsatile growth hormone secretion patterns.

CJC-1295 is commonly studied for:

• Growth hormone signaling — how the pituitary responds to GHRH-like activity

• IGF-1 pathways — how growth hormone signaling influences IGF-1-related activity

• Recovery research — pathways connected to repair, restoration, and rebuilding

• Muscle-support pathways — how protein synthesis and tissue-maintenance signals are studied

• Fat metabolism — pathways connected to how stored energy is processed

• Body-composition research — markers related to lean mass, fat mass, and energy balance

• Pituitary response — how the pituitary releases growth hormone in research settings

CJC-1295 has been studied because it was designed to extend the activity of GHRH-like signaling. Research has reported dose-dependent increases in mean growth hormone concentrations and IGF-1 concentrations after CJC-1295 exposure, while another study reported that pulsatile growth hormone secretion persisted during continuous stimulation by CJC-1295.

For research use only. Not for human consumption, medical use, diagnostic use, or therapeutic application.